K
Kjersti Bakken
Researcher at University of Tromsø
Publications - 38
Citations - 1543
Kjersti Bakken is an academic researcher from University of Tromsø. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 17, co-authored 34 publications receiving 1404 citations. Previous affiliations of Kjersti Bakken include Innlandet Hospital Trust & University of Bergen.
Papers
More filters
Journal ArticleDOI
Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition.
Laure Dossus,Naomi E. Allen,Rudolf Kaaks,Kjersti Bakken,Eiliv Lund,Anne Tjønneland,Anja Olsen,Kim Overvad,Françoise Clavel-Chapelon,Agnès Fournier,Nathalie Chabbert-Buffet,Heiner Boeing,Madlen Schütze,Antonia Trichopoulou,Dimitrios Trichopoulos,Pagona Lagiou,Domenico Palli,Vittorio Krogh,Rosario Tumino,Paolo Vineis,Amalia Mattiello,H. Bas Bueno-de-Mesquita,N. Charlotte Onland-Moret,Petra H.M. Peeters,Vanessa Dumeaux,Maria Luisa Redondo,Eric J. Duell,Emilio Sánchez-Cantalejo,Larraitz Arriola,María Dolores Chirlaque,Eva Ardanaz,Jonas Manjer,Signe Borgquist,A Lukanova,A Lukanova,Eva Lundin,Kay-Tee Khaw,Nicholas J. Wareham,Timothy J. Key,Veronique Chajes,Veronique Chajes,Sabina Rinaldi,Nadia Slimani,Traci Mouw,Valentina Gallo,Elio Riboli +45 more
TL;DR: A reduction in risk of endometrial cancer with factors associated with a lower cumulative exposure to estrogen and/or higher exposure to progesterone, such as increasing number of FTPs and shorter menstrual lifespan is confirmed and support an important role of hormonal mechanisms inendometrial carcinogenesis.
Journal ArticleDOI
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
Konstantinos K. Tsilidis,Naomi E. Allen,Timothy J. Key,Laure Dossus,A Lukanova,Kjersti Bakken,Eiliv Lund,Agnès Fournier,Agnès Fournier,Kim Overvad,Louise Hansen,Anne Tjønneland,Veronika Fedirko,S. Rinaldi,Isabelle Romieu,F. Clavel-Chapelon,F. Clavel-Chapelon,Pierre Engel,Pierre Engel,Rudolf Kaaks,Madlen Schütze,Annika Steffen,Christina Bamia,Antonia Trichopoulou,Dimosthenis Zylis,Giovanna Masala,Valeria Pala,Rocco Galasso,Rosario Tumino,Carlotta Sacerdote,H. B. Bueno-de-Mesquita,F. J. B. van Duijnhoven,Marieke G.M. Braem,N. C. Onland-Moret,Inger T. Gram,L. Rodríguez,Noémie Travier,M-J Sanchez,José María Huerta,Eva Ardanaz,N. Larrañaga,Karin Jirström,Jonas Manjer,Annika Idahl,Nina Ohlson,K-T Khaw,Nicholas J. Wareham,T Mouw,Teresa Norat,Elio Riboli +49 more
TL;DR: This study shows a strong protective association of oral contraceptives and parity with ovarian cancer risk, a higher risk with a late age at menopause, and no association with other reproductive factors.
Journal ArticleDOI
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
TL;DR: The results suggest that HRT could be considered a major determinant for the increasing incidence of breast cancer in Norway.
Journal ArticleDOI
Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition
Kjersti Bakken,Agnès Fournier,Eiliv Lund,Marit Waaseth,Vanessa Dumeaux,F. Clavel-Chapelon,Alban Fabre,Bertrand Hémon,Sabina Rinaldi,Veronique Chajes,Nadia Slimani,Naomi E. Allen,Gillian K Reeves,Sheila Bingham,Kay-Tee Khaw,Anja Olsen,Anne Tjønneland,Laudina Rodríguez,María José Sánchez,Pilar Amiano Etxezarreta,Eva Ardanaz,María José Tormo,Petra H.M. Peeters,Carla H. van Gils,Annika Steffen,Mandy Schulz,Jenny Chang-Claude,Rudolf Kaaks,Rosario Tumino,Valentina Gallo,Teresa Norat,Elio Riboli,Salvatore Panico,Giovanna Masala,Carlos González,Franco Berrino +35 more
TL;DR: Estrogen‐only and combined MHT uses and continuous combined preparations were associated with increased breast cancer risk, and Continuous combined preparations was associated with the highest risk.
Journal ArticleDOI
Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition
Naomi E. Allen,Konstantinos K. Tsilidis,Timothy J. Key,Laure Dossus,Rudolf Kaaks,Eiliv Lund,Kjersti Bakken,Oxana Gavrilyuk,Kim Overvad,Anne Tjønneland,Anja Olsen,Agnès Fournier,Alban Fabre,Françoise Clavel-Chapelon,Nathalie Chabbert-Buffet,Carlotta Sacerdote,Vittorio Krogh,Benedetta Bendinelli,Rosario Tumino,Salvatore Panico,Manuela M. Bergmann,Madlen Schuetze,Fränzel J. B. van Duijnhoven,H. Bas Bueno-de-Mesquita,N. Charlotte Onland-Moret,Carla H. van Gils,Pilar Amiano,Aurelio Barricarte,Maria-Dolores Chirlaque,Maria-Esther Molina-Montes,María-Luisa Redondo,Eric J. Duell,Kay-Tee Khaw,Nicholas J. Wareham,Sabina Rinaldi,Veronika Fedirko,Traci Mouw,Dominique S. Michaud,Elio Riboli +38 more
TL;DR: The finding of a strong increased risk of endometrial cancer with estrogen-only HT and a weaker association with combined HT supports the hypothesis that progestins have an attenuating effect on endometricrial cancer risk.